1,773 Followers on Owler

Adaptimmune

is an England-based biopharmaceutical company that researches and develops novel cell therapeutics for the treatment of cancer and infectious diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Adaptimmune

is an England-based biopharmaceutical company that researches and develops novel cell therapeutics for the treatment of cancer and infectious diseases... Read more
Adaptimmune CEO: Adrian Rawcliffe

CEO

Adrian Rawcliffe

CEO Approval Rating

84/100

2008

PublicMerger Pending with Tcr2 Therapeutics, Inc.NASDAQADAP

Pharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals
2836 NAICS listing

Annual Revenue
$178M
Employees
506
Funding
$683.7M
Acquisitions
1

News

Funding
May 31, 2024
adaptimmune.com
Adaptimmune received $100M in Post-IPO Equity Funding

Adaptimmune Competitors

1Iovance
2Allogene
3Fate Therapeutics
4Medigene
5Emergex Vaccines
6Autolus
7Immunocore
8Immatics
9TCR2
10Gadeta
Unlock 13 + competitors

Trending Companies